CRISPR-Cas12a biosensing via transcription of crRNA from PCR or LAMP products for pathogen detection
- 26 May 2026
- journal article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 310, 118860
Abstract
No abstract availableKeywords
Funding Information
- Shionogi Infectious Disease Research Promotion Foundation
- Shionogi
This publication has 20 references indexed in Scilit:
- PAM-Independent CRISPR-Cas12a System for Specific Assays of Single Nucleotide VariantsJACS Au, 2025
- A PAM-Free One-Step Asymmetric RPA and CRISPR/Cas12b Combined Assay (OAR-CRISPR) for Rapid and Ultrasensitive DNA DetectionAnalytical Chemistry, 2024
- Completely Free from PAM Limitations: Asymmetric RPA with CRISPR/Cas12a for Nucleic Acid AssaysACS Sensors, 2023
- PAM-free loop-mediated isothermal amplification coupled with CRISPR/Cas12a cleavage (Cas-PfLAMP) for rapid detection of rice pathogensBiosensors and Bioelectronics, 2022
- Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A reviewBiosensors and Bioelectronics, 2022
- Suitable primers for GAPDH reference gene amplification in quantitative RT-PCR analysis of human gene expressionGene Reports, 2021
- Detect and destroy: CRISPR-based technologies for the response against virusesCell Host & Microbe, 2021
- Double Rolling Circle Amplification Generates Physically Cross-Linked DNA Network for Stem Cell FishingJournal of the American Chemical Society, 2020
- CRISPR/Cas Systems towards Next-Generation BiosensingTrends in Biotechnology, 2019
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015